AI Governance in Life Sciences: What Quality Leaders Need to Know About ISO/IEC 42001
Article Context:
Deploying AI in regulated environments without a governance framework is not a technology risk. It is a regulatory and reputational risk—and the FDA is already asking about it.
The Question Your Next Auditor Is Already Preparing
Imagine this scenario: An FDA auditor is reviewing your quality management system. Your automated deviation triage is working well. Your predictive analytics have caught two potential failures before they reached patients. Your team is proud of the AI tools they’ve deployed. Then the auditor asks:
“Walk me through your AI governance controls. How do you manage model drift? What is your human accountability framework for AI-influenced quality decisions?”
If your answer is “We don’t have a formal framework yet,” that observation goes into the FDA Form 483. Next to your name.
This is not hypothetical. The FDA’s April 2026 warning letter on uncontrolled AI use in regulated quality environments signaled a clear shift: regulators are no longer treating AI as a curiosity. They are treating it as a regulated system that requires rigorous—and in some respects, more rigorous—oversight than any other software in your quality stack.
Industry data tells a stark story: 87% of life sciences organizations plan to deploy AI in quality processes within two years. Fewer than 12% currently have governance structures capable of managing AI lifecycle risks in a Good Practice (GxP) environment. That gap is where audit risk lives.
Why AI Cannot Be Governed Like Other Software.
Here is the reframe that changes everything: AI cannot be treated like other software because AI logic is learned, not programmed.
Traditional software follows deterministic rules. You can validate it at a point in time and be confident the system will do tomorrow what it did today. AI breaks that assumption at the foundation. A machine learning model trained on historical deviation data today may behave differently six months from now—not because anyone changed the code, but because the data it encounters has shifted. This is called a model drift. It is silent, gradual, and invisible to teams not actively monitoring it.
“Organizations will need to manage not just the software’s functionality, but also its data, its drift from initial training, its performance over time, and the explainability of every decision it influences.”
The compliance question for AI is not “Did we validate it?” The compliance question is “Can we demonstrate that this system remains trustworthy, governed, and accountable across its entire operational lifecycle?” That demands a fundamentally different framework.
What Is ISO/IEC 42001, and Why Is It the Standard That Matters?
ISO/IEC 42001:2023 is the world’s first international standard for Artificial Intelligence Management Systems (AIMS). It establishes a comprehensive framework for organizations to responsibly develop, deploy, and govern AI across its full lifecycle—from data collection and model development through deployment, monitoring, retraining, and decommissioning.
The standard organizes AI governance across four critical domains: Leadership and Accountability, AI Lifecycle Management, Data and Model Governance, and Continuous Performance Evaluation. Critically, it is designed to harmonize with the EU AI Act, FDA’s draft AI guidance, EU GMP Annex 22, the ISPE GAMP AI Guide, and existing CSA frameworks—so organizations that build an AIMS on ISO/IEC 42001 satisfy multiple regulatory requirements through a single governance architecture.
CSA directs quality teams to apply critical thinking first—to understand the intended use of a software system, identify the functions that pose genuine risk to patient safety, product quality, or data integrity, and design assurance activities proportional to that risk. Documentation follows from thinking; it does not replace it.
Compliance Group: The Only Life Sciences Firm with ISO/IEC 42001 Certification
Compliance Group is the only life sciences consulting firm to have achieved ISO/IEC 42001:2023 certification for its own AI Management System. This is an independently verified, audited certification—not a marketing claim. Our organizational processes, including data management, risk assessment, model governance, and human oversight controls, meet the highest global standard for responsible AI management.
iQuality is built entirely within this certified framework. Every CLAiRE AI agent in the iQuality platform operates under governance controls that are themselves ISO/IEC 42001 compliant, including strict data governance, role-based human-in-the-loop controls, continuous drift monitoring, and explainable AI outputs. When an auditor asks why the system flagged a particular deviation as high risk, you can show them the logic—not just the output.
Build Your AI Governance Framework Before the FDA Builds It for You
Your next FDA audit will include AI governance questions. Visit iquality.ai to request a 30-minute demo or take our free AI Readiness Assessment. In 45 minutes with a Compliance Group expert, you’ll receive a scored readiness snapshot, your top three governance gaps, and a clear view of what a 90-day AI governance implementation could look like.
Visit iquality.ai →
Speed without shortcuts. Compliance without complexity. Intelligence without compromise.
Submit the form below, and our expert will reach out to assist you!